# UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis

> **NCT00638469** · NA · UNKNOWN · sponsor: **Medical University of Graz** · enrollment: 10 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **RADIATION:** UVB-311nm
- **OTHER:** No treatment

## Key facts

- **NCT ID:** NCT00638469
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638469, "UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00638469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*